Sancy Leachman, M.D., Ph.D.

Sancy Leachman, M.D., Ph.D., is an Adjunct Professor of Dermatology in the School of Medicine at Oregon Health & Science University. Her research focuses on melanoma genetics, skin cancer prevention, and precision oncology, with particular emphasis on risk communication and decision aids for dysplastic nevi. Recent work includes randomized trials on quantitative versus qualitative risk framing, adjuvant pembrolizumab for Stage IIB/IIC melanoma, and pioneering applications of generative AI and digital twins to enhance randomized clinical trials and advance precision medicine. She has also contributed to space oncology through a comprehensive scoping review. Her research integrates clinical dermatology, genetics, and public health to improve early detection and treatment outcomes.